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Background
The androgen receptor (AR) is an important determi-
nant of normal and malignant prostate growth. There-
fore, a good understanding of the factors that regulate
the transactivation of the AR is essential and could pro-
vide a better strategy to control prostate tumor growth,
particularly in patients suffering from the hormone-
refractory and the advanced stages of the disease. How-
ever, transcriptional activation by the AR is a complex
and orchestrated process requiring multiple coregula-
tors. Several coregulators have already been identified,
including proteasome components, chromatin-re-model-
ing complexes and heat shock proteins. Others however
remain uncharacterized and their role in AR transactiva-
tion is poorly understood. One such coregulator is the
nuclear-resident, AR co-activator, Bag-1L. Overexpression
of Bag-1L and the amplification of its gene have been
reported in the hormone-refractory and metastatic stages
of prostate cancer and in androgen-independent prostate
cancer cells (AIPC). However the exact mechanism of
Bag-1L-mediated regulation of AR action in prostate can-
cer is unclear.
Materials and methods
To confirm the contribution of Bag-1L to AR response in
prostate cancer, we have downregulated the expression
of Bag-1L in the androgen-dependent prostate cancer
cell line LNCaP using RNAi. Subsequently we performed
genome-wide mapping of Bag-1L, using genome-wide
chromatin immunoprecipitation (ChIP-seq). Lastly, the
ability of AR and Bag-1L to interact with one another
was assessed by domain mapping experiments using GST
pulldown assays.
Results
Here we show that Bag-1L depletion by RNA interference
in the prostate cell line LNCaP significantly reduces the
hormone response of several AR-target genes. In agree-
ment, Bag-1L and AR co-localize to a large number of
regulatory regions of AR-target genes as identified by
ChIP-sequencing. Furthermore, domain mapping experi-
ments identified the first 128 N-terminal amino acids of
Bag-1L as necessary for enhancing the transactivation func-
tion of the receptor. This sequence contains a duplication
of a GARRPR motif, which we identified as the main inter-
action site between Bag-1L and AR. We were able to
further confirm the importance of this motif by amino acid
substitutions of the sequence, which impairs the AR and
Bag-1L-mediated AR transactivation. Intriguingly, overex-
pression of the N-terminal sequence of Bag-1L encompass-
ing the conserved hexapeptide sequences exerts a
dominant negative effect on androgen-mediated gene
expression and androgen-dependent tumor growth. The
GARRPR was also identified in other regulators of AR
activity, such as Huntington associated protein 1, nuclear
receptor coactivator 4 and p21-activated kinase 6.
Conclusions
We have identified a novel AR binding motif different
from the previously described LXXLL and FXXLF
sequences of other coactivators of AR. In the long-term
we propose to use this knowledge to design novel drugs
targeting this interaction site for the therapeutic interven-
tion of prostate cancer.
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